FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888949563> ?p ?o ?g. }

• W2888949563 endingPage "245" @default.
• W2888949563 startingPage "245" @default.
• W2888949563 abstract "Adjuvant tamoxifen reduces the recurrence rate of estrogen receptor (ER)-positive breast cancer. Previous in vitro studies have suggested that tamoxifen can affect the cancerous inhibitor of protein phosphatase 2A (CIP2A)/protein phosphatase 2A (PP2A)/phosphorylation Akt (pAkt) signaling in ER-negative breast cancer cells. In addition to CIP2A, SET nuclear proto-oncogene (SET) oncoprotein is another intrinsic inhibitor of PP2A, participating in cancer progression. In the current study, we explored the clinical significance of SET, CIP2A, PP2A, and Akt in patients with ER-positive breast cancer receiving adjuvant tamoxifen. A total of 218 primary breast cancer patients receiving adjuvant tamoxifen with a median follow-up of 106 months were analyzed, of which 17 (7.8%) experienced recurrence or metastasis. In an immunohistochemical (IHC) stain, SET overexpression was independently associated with worse recurrence-free survival (RFS) (hazard ratio = 3.72, 95% confidence interval 1.26⁻10.94, p = 0.017). In silico analysis revealed mRNA expressions of SET, PPP2CA, and AKT1 significantly correlated with worse RFS. In vitro, SET overexpression reduced tamoxifen-induced antitumor effects and drove luciferase activity in an Estrogen receptor element (ERE)-dependent manner. In conclusion, SET is a prognostic biomarker in patients with primary ER-positive breast cancer receiving adjuvant tamoxifen and may contribute to the failure of the tamoxifen treatment by modulating the ER signaling. Our study warrants further investigation into the potential role of SET in ER-positive breast cancer." @default.
• W2888949563 created "2018-09-07" @default.
• W2888949563 creator A5003711312 @default.
• W2888949563 creator A5004095602 @default.
• W2888949563 creator A5016888840 @default.
• W2888949563 creator A5033428202 @default.
• W2888949563 creator A5048096590 @default.
• W2888949563 creator A5055292882 @default.
• W2888949563 creator A5062046621 @default.
• W2888949563 creator A5079871884 @default.
• W2888949563 creator A5081940417 @default.
• W2888949563 creator A5082241942 @default.
• W2888949563 creator A5084039348 @default.
• W2888949563 date "2018-08-28" @default.
• W2888949563 modified "2023-10-14" @default.
• W2888949563 title "SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment" @default.
• W2888949563 cites W1585521882 @default.
• W2888949563 cites W1864994387 @default.
• W2888949563 cites W1961026612 @default.
• W2888949563 cites W1966585685 @default.
• W2888949563 cites W1972236331 @default.
• W2888949563 cites W1981083415 @default.
• W2888949563 cites W1981952679 @default.
• W2888949563 cites W1983202767 @default.
• W2888949563 cites W1985213644 @default.
• W2888949563 cites W1985911963 @default.
• W2888949563 cites W1987474302 @default.
• W2888949563 cites W1991455388 @default.
• W2888949563 cites W1992060900 @default.
• W2888949563 cites W2015473392 @default.
• W2888949563 cites W2034174983 @default.
• W2888949563 cites W2044702943 @default.
• W2888949563 cites W2053645860 @default.
• W2888949563 cites W2053791947 @default.
• W2888949563 cites W2074086229 @default.
• W2888949563 cites W2083459920 @default.
• W2888949563 cites W2083832170 @default.
• W2888949563 cites W2085934079 @default.
• W2888949563 cites W2100271891 @default.
• W2888949563 cites W2103938232 @default.
• W2888949563 cites W2105882193 @default.
• W2888949563 cites W2118728607 @default.
• W2888949563 cites W2124252702 @default.
• W2888949563 cites W2131584282 @default.
• W2888949563 cites W2131769274 @default.
• W2888949563 cites W2134807611 @default.
• W2888949563 cites W2151929173 @default.
• W2888949563 cites W2158492983 @default.
• W2888949563 cites W2158545959 @default.
• W2888949563 cites W2160377567 @default.
• W2888949563 cites W2161977537 @default.
• W2888949563 cites W2165038925 @default.
• W2888949563 cites W2165597190 @default.
• W2888949563 cites W2167166423 @default.
• W2888949563 cites W2239996330 @default.
• W2888949563 cites W2465526147 @default.
• W2888949563 cites W2489370798 @default.
• W2888949563 cites W2552667611 @default.
• W2888949563 cites W2597872842 @default.
• W2888949563 cites W2623381999 @default.
• W2888949563 doi "https://doi.org/10.3390/jcm7090245" @default.
• W2888949563 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6162815" @default.
• W2888949563 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30154367" @default.
• W2888949563 hasPublicationYear "2018" @default.
• W2888949563 type Work @default.
• W2888949563 sameAs 2888949563 @default.
• W2888949563 citedByCount "14" @default.
• W2888949563 countsByYear W28889495632019 @default.
• W2888949563 countsByYear W28889495632020 @default.
• W2888949563 countsByYear W28889495632021 @default.
• W2888949563 countsByYear W28889495632022 @default.
• W2888949563 countsByYear W28889495632023 @default.
• W2888949563 crossrefType "journal-article" @default.
• W2888949563 hasAuthorship W2888949563A5003711312 @default.
• W2888949563 hasAuthorship W2888949563A5004095602 @default.
• W2888949563 hasAuthorship W2888949563A5016888840 @default.
• W2888949563 hasAuthorship W2888949563A5033428202 @default.
• W2888949563 hasAuthorship W2888949563A5048096590 @default.
• W2888949563 hasAuthorship W2888949563A5055292882 @default.
• W2888949563 hasAuthorship W2888949563A5062046621 @default.
• W2888949563 hasAuthorship W2888949563A5079871884 @default.
• W2888949563 hasAuthorship W2888949563A5081940417 @default.
• W2888949563 hasAuthorship W2888949563A5082241942 @default.
• W2888949563 hasAuthorship W2888949563A5084039348 @default.
• W2888949563 hasBestOaLocation W28889495631 @default.
• W2888949563 hasConcept C11960822 @default.
• W2888949563 hasConcept C121608353 @default.
• W2888949563 hasConcept C126322002 @default.
• W2888949563 hasConcept C143998085 @default.
• W2888949563 hasConcept C178666793 @default.
• W2888949563 hasConcept C204232928 @default.
• W2888949563 hasConcept C2777176818 @default.
• W2888949563 hasConcept C2777863537 @default.
• W2888949563 hasConcept C2777982462 @default.
• W2888949563 hasConcept C2779013556 @default.
• W2888949563 hasConcept C389152 @default.
• W2888949563 hasConcept C502942594 @default.
• W2888949563 hasConcept C530470458 @default.

• next